Duodenal neuroendocrine tumors (NETs) comprise 2–3% of all GI endocrine tumors and are
increasing in frequency. These include gastrinomas, somatostatinomas, nonfunctional …

Gastrointestinal neuroendocrine tumors (GI-NETs) are rare neoplasms, like all NETs.
However, the incidence of GI-NETS has been increasing in recent years. Gastric NETs (G …

Duodenal neuroendocrine tumors (NETs) are located in the duodenum and may or may not
be associated with a functional clinical syndrome. The term duodenal NET includes all …

Gastric neuroendocrine neoplasms (NENs) are increasing in frequency and have a varied
spectrum with regard to histology, clinicopathologic background, stage, and prognosis. They …

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are relatively rare and complex
neoplasms that present many clinical challenges. Most GEP-NETs are sporadic, but they …

Gastric neuroendocrine neoplasms (g-NENs) represent the most frequent digestive NENs
and are increasingly recognized due to expanding indications of upper gastrointestinal …

Abstract Gastro-entero-pancreatic (GEP) neuroendocrine tumors (NETs) are rare
neoplasms, although their prevalence has increased substantially over the past three …

Neuroendocrine gastroenteropancreatic tumours (GEP-NET) constitute a heterogeneous
group of tumours with their origin in neuroendocrine cells of the embryological gut, most …

Only relatively recently has there been an increased clinical recognition and
characterization of the heterogenous group of rare gastroenteropancreatic neuroendocrine …

Introduction Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are uncommon but
clinically challenging and fascinating tumors. GEP-NETs present as either functional or as …